Community Health Systems financials
$2.91+0.69%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B |
| Gross profit | $10.62B | $10.69B | $10.50B | $10.24B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B |
| Gross margin | 85.1% | 84.6% | 84.0% | 83.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $1.49B | $542.0M | $957.0M | $821.0M | $1.40B | $1.13B | $650.0M | $208.0M | -$1.88B | -$860.0M |
| Net income | $509.0M | -$516.0M | -$133.0M | $46.0M | $230.0M | $511.0M | -$675.0M | -$788.0M | -$2.46B | -$1.72B |
| Net margin | 4.1% | −4.1% | −1.1% | 0.4% | 1.9% | 4.3% | −5.1% | −5.6% | −16.0% | −9.3% |
| Diluted EPS | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-5.93 | $-6.99 | $-22.00 | $-15.54 |
| EBITDA | $1.51B | $1.33B | $1.38B | $1.43B | $1.97B | $1.73B | $1.49B | $1.59B | $1.07B | $2.17B |
| Operating cash flow | $543.0M | $480.0M | $210.0M | $300.0M | -$131.0M | $2.18B | $385.0M | $274.0M | $773.0M | $1.14B |
| Free cash flow | $208.0M | $120.0M | -$257.0M | -$115.0M | -$600.0M | $1.74B | -$53.0M | -$253.0M | $209.0M | $393.0M |
| Diluted shares | 135.0M | 132.1M | 130.4M | 130.1M | 130.6M | 116.5M | 113.7M | 112.7M | 111.8M | 110.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $260.0M | $37.0M | $38.0M | $118.0M | $507.0M | $1.68B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $10.63B | $11.67B | $11.65B | $11.82B | $12.37B | $12.37B |
| Total assets | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B |
| Total liabilities | $14.04B | $15.37B | $15.28B | $15.40B | $16.03B | $17.06B |
| Shareholders' equity | -$1.16B | -$1.68B | -$1.15B | -$1.27B | -$1.29B | -$1.54B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology